Cargando…
A Retrospective Real-World Evidence Evaluation of the Characteristics of Exocrine Pancreatic Insufficiency in Patients With Chronic Pancreatitis and Type 2 Diabetes Treated With Pancrelipase in the United States
This retrospective real-world data analysis assessed clinical/health care professional characteristics of gastrointestinal symptom profiles in pancrelipase-treated patients with exocrine pancreatic insufficiency symptoms and chronic pancreatitis (CP) or type 2 diabetes (T2D). METHODS: Data were from...
Autores principales: | Rosenberg, Jonathan, Reddy, Manchikanti Nagarjuna, Seelam, Prafulla, Li, Olivia, Twal, Janine, Pack, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184798/ https://www.ncbi.nlm.nih.gov/pubmed/37099771 http://dx.doi.org/10.1097/MPA.0000000000002203 |
Ejemplares similares
-
Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis
por: Krishnamurty, Devi Mukkai, et al.
Publicado: (2009) -
Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency
por: Nakajima, Kei, et al.
Publicado: (2012) -
Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
por: Baker, Susan S
Publicado: (2008) -
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis
por: Konstan, Michael W., et al.
Publicado: (2010) -
Pancreatic Exocrine Insufficiency in Pancreatic Cancer
por: Vujasinovic, Miroslav, et al.
Publicado: (2017)